Related Experiment Video
Updated: Jun 12, 2026

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
Published on: February 25, 2011
[Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity]
Li-li Zhang1, Qian Ding, Jin-biao Zhan
1Department of Biochemistry and Genetics, College of Medicine, Zhejiang University, Hangzhou 310058, China.
Objective:
To clone and produce ribosome inactivating protein MAP30 from the seeds of Momordica charantia L(bitter melon), and to evaluate the biological activity of the recombinant protein.
Methods:
The DNA sequence encoding MAP30 was cloned from the fresh seeds of Momordica charantia by PCR, the target DNA fragments were sequenced after T-A cloning. The expression plasmid was constructed by inserting the MAP30 fragment into vector pET30a. MAP30 was expressed in E.coli by addition of IPTG into final concentration of 1.0 mmol/L. The recombinant MAP30 was identified by SDS-PAGE, and the biological activity of MAP30 protein was evaluated by using MTT assay in cancer cells and normal cells following fluid-phase endocytosis.
Result:
The nucleotide and amino acid sequences of the cloned MAP30 were identical with those of reported MAP30. The solubility of recombinant protein was analyzed by SDS-PAGE, and the MAP30 was mainly produced in soluble form. The recombinant MAP30 showed a greater cytotoxicity to cancer cells than that to normal cells.
Conclusion:
The gene of MAP30 has been successfully cloned.The recombinant MAP30 protein expressed by E.coli is bioactive.
Insights
Bitter melon
Area of Science:
- Molecular Biology
- Biochemistry
- Pharmacology
Background:
- Momordica charantia L. (bitter melon) seeds contain ribosome inactivating proteins (RIPs).
- MAP30 is a RIP with potential therapeutic applications.
- Efficient production of bioactive MAP30 is crucial for further research.
Purpose of the Study:
- To clone and produce recombinant ribosome inactivating protein MAP30 from bitter melon seeds.
- To assess the biological activity and cytotoxicity of the recombinant MAP30 protein.
Main Methods:
- Polymerase chain reaction (PCR) and T-A cloning were used to isolate the MAP30 gene.
- The MAP30 gene was inserted into the pET30a vector for expression in E. coli.
- Recombinant MAP30 expression was induced using IPTG, and protein activity was evaluated via MTT assay.
Main Results:
- The cloned MAP30 sequences (nucleotide and amino acid) matched reported sequences.
- SDS-PAGE confirmed the production of soluble recombinant MAP30.
- The recombinant MAP30 exhibited higher cytotoxicity towards cancer cells compared to normal cells.
Conclusions:
- The gene encoding MAP30 was successfully cloned and expressed in E. coli.
- The recombinant MAP30 protein demonstrated significant bioactivity and selective cytotoxicity.
Related Concept Videos
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Ribozymes
Ribozymes can be...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Inhibitors of Bacterial Protein Synthesis

